Instil Bio, Inc. - Common Stock — Cash Flow (NASDAQ:TIL) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -122.14 M-180.16 M-82.03 M-55.7 M-36.62 M -23.61 M Cash from investing activities -474.4 M114.54 M41.13 M53.97 M25.48 M 21.24 M Cash from financing activities 393.16 M71.89 M8.08 M1.75 M7.29 M 378 K Free cash flow -122.14 M-180.16 M-82.03 M-55.7 M-36.62 M -23.61 M

News

Citizens analyst reiterates Market Perform rating on Instil Bio stock

Instil Bio ends license agreement with ImmuneOnco for AXN-2510 and AXN-27M

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.99%

Baird downgrades Instil Bio stock to Neutral on AXN-2510 discontinuation

Dow Jumps Over 400 Points; US Services Activity Falls In December - Aeva Technologies (NASDAQ:AEVA), Alumis (NASDAQ:ALMS)

Instil Bio stock falls after subsidiary discontinues AXN-2510 development

Instil Bio Stock Crashed 50% - Instil Bio (NASDAQ:TIL)

US Stocks Mixed; Nasdaq Gains Over 50 Points - Alumis (NASDAQ:ALMS), AngioDynamics (NASDAQ:ANGO)

Citizens reiterates Market Perform rating on Instil Bio stock

Instil Bio stock rating reiterated at Buy by H.C. Wainwright

Instil Bio stock rating reiterated by JMP, awaits more robust results

Instil Bio Posts Wider Loss in Q2